New Search

Export article

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, the Oxford COVID Vaccine Trial Group, Sandra Belij-Rammerstorfer, Christina Dold, , , Ciaran Gilbride, Rachel Halkerston, Jennifer Hill,
Show More
Nature Medicine pp 1-1; doi:10.1038/s41591-021-01372-z

The publisher has not yet granted permission to display this abstract.
Keywords: Author Correction / dose induces / SARS CoV / ChAdOx1 nCoV / induces multifunctional / vaccine ChAdOx1 / booster dose / multifunctional antibody

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "Nature Medicine" .
Back to Top Top